Librela RSS Authorised This medicine is authorised for use in the European Union bedinvetmab Medicine Veterinary Authorised
Page contentsPage contents Overview Product information Product details Authorisation details Assessment history News on Librela Topics Application under evaluation CVMP opinion European Commission decision OverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website. Librela : EPAR - Medicine overviewReference Number: EMA/518254/2020 English (EN) (81.94 KB - PDF)First published: 06/05/2021 Last updated: 31/05/2024 View Other languages (25) български (BG) (93.36 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View español (ES) (81.97 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View čeština (CS) (93.99 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View dansk (DA) (83.34 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View Deutsch (DE) (82.76 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View eesti keel (ET) (82.18 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View ελληνικά (EL) (93.76 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View français (FR) (82.44 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View hrvatski (HR) (92.27 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View íslenska (IS) (83.29 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View Gaeilge (GA) (83.57 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View italiano (IT) (82.29 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View latviešu valoda (LV) (94.29 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View lietuvių kalba (LT) (94.03 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View magyar (HU) (94.15 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View Malti (MT) (95.95 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View Nederlands (NL) (82.05 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View norsk (NO) (82 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View polski (PL) (95.62 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View português (PT) (83.01 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View română (RO) (94.17 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View slovenčina (SK) (94.08 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View slovenščina (SL) (82.27 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View Suomi (FI) (81.54 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View svenska (SV) (82.05 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View Product information Librela : EPAR - Product information English (EN) (81.49 KB - PDF)First published: 06/05/2021 Last updated: 31/05/2024 View Other languages (25) български (BG) (91.78 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View español (ES) (81.51 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View čeština (CS) (92.48 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View dansk (DA) (82.05 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View Deutsch (DE) (81.72 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View eesti keel (ET) (81.22 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View ελληνικά (EL) (91.79 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View français (FR) (81.63 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View hrvatski (HR) (91.56 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View íslenska (IS) (81.52 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View Gaeilge (GA) (81.36 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View italiano (IT) (81.76 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View latviešu valoda (LV) (92.14 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View lietuvių kalba (LT) (92.19 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View magyar (HU) (92.76 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View Malti (MT) (93.86 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View Nederlands (NL) (81.15 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View norsk (NO) (81.52 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View polski (PL) (93.22 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View português (PT) (82.53 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View română (RO) (91.73 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View slovenčina (SK) (81.75 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View slovenščina (SL) (81.76 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View Suomi (FI) (81.11 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View svenska (SV) (81.47 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View Librela : EPAR - All authorised presentations English (EN) (81.94 KB - PDF)First published: 06/05/2021 Last updated: 31/05/2024 View Other languages (25) български (BG) (93.36 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View español (ES) (81.97 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View čeština (CS) (93.99 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View dansk (DA) (83.34 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View Deutsch (DE) (82.76 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View eesti keel (ET) (82.18 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View ελληνικά (EL) (93.76 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View français (FR) (82.44 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View hrvatski (HR) (92.27 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View íslenska (IS) (83.29 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View Gaeilge (GA) (83.57 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View italiano (IT) (82.29 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View latviešu valoda (LV) (94.29 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View lietuvių kalba (LT) (94.03 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View magyar (HU) (94.15 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View Malti (MT) (95.95 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View Nederlands (NL) (82.05 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View norsk (NO) (82 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View polski (PL) (95.62 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View português (PT) (83.01 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View română (RO) (94.17 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View slovenčina (SK) (94.08 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View slovenščina (SL) (82.27 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View Suomi (FI) (81.54 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View svenska (SV) (82.05 KB - PDF) First published: 06/05/2021 Last updated: 31/05/2024 View Product details Name of medicine Librela Active substance bedinvetmab International non-proprietary name (INN) or common name bedinvetmab Pharmacotherapeutic groupOther analgesics and antipyreticsbedinvetmab Authorisation details EMA product number EMEA/V/C/005180 Opinion adopted 09/09/2020 Assessment history Expand section Collapse section Changes since initial authorisation of medicine Librela : EPAR - Procedural steps taken and scientific information after authorisation English (EN) (81.94 KB - PDF)First published: 21/02/2022 Last updated: 31/05/2024 View Initial marketing authorisation documents Librela : EPAR - Public assessment reportAdopted English (EN) (81.49 KB - PDF)First published: 06/05/2021 Last updated: 31/05/2024 View CVMP summary of positive opinion for LibrelaAdopted Reference Number: EMA/CVMP/438128/2020 English (EN) (133.73 KB - PDF)First published: 11/09/2020 View News on Librela Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 4-6 November 202507/11/2025 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 3-5 December 202406/12/2024 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 13-14 February 202416/02/2024 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 15-16 May 202322/05/2023 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 14-16 February 202317/02/2023 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 14-16 February 202317/02/2023 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 8-10 November 202211/11/2022 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 10-12 May 202213/05/2022 Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 13-15 July 202116/07/2021 Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 8-9 September 202011/09/2020 Topics Medicines This page was last updated on 31/05/2024 Share this page